Clinical Trial Update: A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating Fruquintinib with hepatic arterial infusion in liver-metastatic colorectal cancer after second-line therapy failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN